12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Atreca (BCEL) saw a 102.7% increase, while Sagimet Biosciences (SGMT) rose 36.13%. Cyclerion Therapeutics (CYCN) and Galera Therapeutics (GRTX) also saw gains. Conversely, 180 Life Sciences (ATNF) and Cytokinetics (CYTK) faced sharp declines, along with Evoke Pharma (EVOK) and Omega Therapeutics (OMGA).

January 11, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
180 Life Sciences' shares fell by 26.7% to $0.22, with a market cap of $2.2 million.
A significant drop of 26.7% in ATNF's stock price is a strong bearish signal, indicating negative investor sentiment or adverse developments.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Cytokinetics' stock decreased by 23.15% to $78.11, with a market cap of $7.6 billion.
The substantial decline in CYTK's stock price could reflect market reactions to negative news or disappointing results, suggesting a bearish short-term outlook.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Atreca's stock soared by 102.7% to $0.22, with a market cap of $8.6 million.
A surge of 102.7% in stock price is a significant short-term bullish signal, indicating strong investor interest or a positive catalyst.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Cyclerion Therapeutics' shares rose by 19.89% to $4.4, with a market cap of $10.7 million.
The 19.89% increase in CYCN's stock price could be driven by investor optimism or company-specific news, likely to have a positive short-term impact.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Galera Therapeutics' stock increased by 14.48% to $0.22, with a market cap of $12.0 million.
GRTX's stock price gain indicates a positive trend, which may continue in the short term based on market momentum.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Sagimet Biosciences' stock increased by 36.13% to $7.12, with a market cap of $163.0 million.
A 36.13% rise in stock price suggests positive market sentiment or news that could drive short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90